Arsenic‐trioxide‐induced apoptosis of chronic lymphocytic leukemia cells
Authors:
- 19 February 2010
- journal article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 32 (1p1) , e77-e85
Abstract
Chronic lymphocytic leukemia (CLL) cells are characterized by defective apoptosis which leads to their extended survival. Arsenic trioxide (As(2)O(3)) was reported to induce cell death in many malignant cells, but the specific pathway of As(2)O(3)-induced apoptosis/necrosis remains controversial. Our aim was to determine if As(2)O(3) kills CLL cells through apoptosis and whether this is accompanied by reduction in Bcl-2 levels. Cells from nine patients with CLL were incubated with increasing concentrations of As(2)O(3) (0.5-2 microM) for 2, 7, or 14 days. Cells viability was measured using Alamar Blue assay and apoptosis using human Annexin V-FITC and propidium iodine (PI) kit (BMS306FI; Bender MedSystems, Vienna, Austria). Intracellular Bcl-2, Bax, and caspase-3 levels were measured by flow cytometry. As(2)O(3) significantly reduced CLL cell viability (P < 0.01) and induced apoptotic cell death in a time- and dose-dependent manner. After 7 days, CLL cells showed a significant decrease in mean fluorescence intensity (MFI) of Bcl-2 on flow cytometry study. Bax and caspase-3 levels showed significant decrease in MFI only after prolonged incubations (7 and 14 days) and mostly at higher concentrations of As(2)O(3). The mechanism underlying the reduction in viability of CLL cells incubated with As(2)O(3) is mediated by induction of apoptosis maybe through the down-regulation of Bcl-2. Further studies are needed to elucidate the potential therapeutic role of As(2)O(3) in CLL.Keywords
This publication has 26 references indexed in Scilit:
- Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse modelAnnals of Oncology, 2008
- Mitochondria as the target of the pro-apoptotic protein BaxBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2006
- Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?Hematological Oncology, 2006
- The Emerging Role of Arsenic Trioxide as an Immunomodulatory Agent in the Management of Multiple MyelomaActa Haematologica, 2006
- DHMEQ, a new NF-κB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cellsLeukemia, 2006
- A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cellsLeukemia, 2004
- Inhibition of NF-κB essentially contributes to arsenic-induced apoptosisBlood, 2003
- Arsenic-Induced Apoptosis in Malignant CellsIn vitroLeukemia & Lymphoma, 2000
- Arsenic induces apoptosis in B‐cell leukaemic cell lines in vitro: activation of caspases and down‐regulation of Bcl‐2 proteinBritish Journal of Haematology, 1998
- Action of Iron, Cod-liver Oil, and Arsenic on the Globular Richness of the BloodThe American Journal of the Medical Sciences, 1878